Figure 2.Lasso regression analysis results and partial likelihood deviance for the Lasso regression in infliximab (A), corticosteroids (B), golimumab (C), or 5-ASA (D) treatment cohorts. (E) Venn diagram showing overlapping key genes in Lasso regression.
